Die Wirkungen der Corticosteroide auf den Kohlenhydratstoffwechsel

  • H. Zimmermann
Part of the Handbuch der inneren Medizin book series (INNEREN, volume 7 / 2 / A)


Im menschlichen Organismus werden in der Nebennierenrinde (NNR) sowie in den Testes bzw. in den Ovarien Steroidhormone gebildet und sezerniert.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abelove, W.A., Paschkis, K.E.: Comparison of the diabetogenic action of cortisone and growth hormone in different species. Endocrinology 55, 637(1954).PubMedGoogle Scholar
  2. Alexander, R.W.: Detection of subclinical diabetes in industry using glucocorticoid provocation. J. occup. Med. 10, 278(1968).Google Scholar
  3. Alexander, R.W., Forsham, P.H., Grodsky, G. M.: Early insulin response to intravenous glucose in steroid-stress-diabetes. Metabolism 18, 248(1969).PubMedGoogle Scholar
  4. Angeli, I., Vertes, L.: Orale Kontrazeptiva und Kohlenhydratstoffwechsel. In: Diabetes mellitus, Salzburg 1973 (Hrsg. Beringer, A.). Wien-München-Bern: W. Maudrich 1973.Google Scholar
  5. Arion, W.J., Nordlie, R. C.: Biological regulation of inorganic pyrophosphate-glucose-phosphotransferase and glucose-6-phosphatase. Activation by triamcinolone in vivo in the presence of actinomycin D. J. biol. Chem. 242, 2207(1967).PubMedGoogle Scholar
  6. Asfeldt, V.H.: Hypophyseo-adrenocortical function in diabetes mellitus. Acta med. scand. 191, 349(1972).PubMedGoogle Scholar
  7. Asfeldt, V.H., Jörgensen, K. R.: Plasma corticosteroid, plasma insulin and blood sugar of normal fasting and diabetic subjects with or without hypercorticism. Acta endocr. (Kbh.) 58, 643(1968).Google Scholar
  8. Ashmore, J.: The effects of glucocorticoids on insulin action. Diabetes 13, 349(1964).PubMedGoogle Scholar
  9. Ashmore, J., Cahill, G. F., Hillman, R., Renold, A.E.: Adrenal cortical regulation of hepatic glucose metabolism. Endocrinology 62, 621(1958).PubMedGoogle Scholar
  10. Ashmore, J., Morgan, D.: Metabolic effects of adrenal glucocorticoid hormones. In: The adrenal cortex (ed. Eisenstein A.B.). Boston: Little, Brown & Co. 1967.Google Scholar
  11. Ashmore, J., Weber, C.: The role of glucose-6-phosphatase in the regulation of carbohydrate metabolism. Vitam. and Horm. 17, 91(1959).Google Scholar
  12. Auinger, W., Gitsch, E., Thalhammer, O.: Versuche zur Erfassung praediabetischer Frauen. Wien. klin. Wschr. 77, 1025(1965).PubMedGoogle Scholar
  13. Azuma, T., Eisenstein, A.B.: Effect of adrenal steroids on carbohydrate metabolism in various animal species. Endocrinology 75, 521(1964).PubMedGoogle Scholar
  14. Baird, J.M., Munro, D.S.: Addison’s disease with diabetes mellitus a case treated with cortisone. Lancet 1954 I, 962.Google Scholar
  15. Barbosa, J., Seal, U.S., Doe, R. P.: Effects of anabolic steroids on hormone binding proteins, serum Cortisol and serum nonprotein-bound Cortisol. J. clin. Endocr. 32, 232(1971).PubMedGoogle Scholar
  16. Bastenie, P.A.: Cortico surrenale et diabete humain, 1 vol. Paris: Masson 1956.Google Scholar
  17. Bastenie, P.A.: Endocrine disorders and diabetes. In: Handbuch des Diabetes mellitus (Hrsg. Pfeiffer E.F.). München: Lehmanns Verlag 1971.Google Scholar
  18. Bastenie, P.A., Conard, V., Franckson, J.R.M.: Effect of cortisone on carbohydrate metabolism measured by the “glucoseassimilation coefficient”. Diabetes 3, 205(1954).PubMedGoogle Scholar
  19. Beck, J.C., McGarry, E.E.: Physiological importance of Cortisol. Brit. med. Bull. 18, 134(1962).PubMedGoogle Scholar
  20. Becker, B.: Diabetic retinopathy. Ann. intern. Med. 37, 273(1952).PubMedGoogle Scholar
  21. Becker, B., Maengwyn-Davies G.D., Rosen, D., Friedenwald, J.S., Winter, F.C.: The adrenal cortex and B-vitamins in diabetic retinopathy. Diabetes 3, 273(1952).Google Scholar
  22. Begemann, R., Kaboth, W.: Nebenwirkungen der Cortisonderivate. Internist (Berl.) 8, 85(1967).Google Scholar
  23. Bellamy, D., Phillipps, J.G., Jones, I.C., Leonard, R.A.: The uptake of Cortisol by rat tissues. Biochem. J. 85, 537(1962).PubMedGoogle Scholar
  24. Bellens, R., Bastenie, P.A.: Experimental steroid diabetes. In: Handbuch des Diabetes mellitus (Hrsg. Pfeiffer E.F.). München: Lehmanns Verlag 1969.Google Scholar
  25. Bellens, R., Corvilain, J., Conrad, V., Bastenie, P.A.: Maladie d’Addison et diabete. Acta clin. belg. 13, 80(1958).PubMedGoogle Scholar
  26. Berger, S., Downey, J.L., Traisman, H.S., Metz, R.: Mechanism of the cortisone-modified glucose tolerance test. New Engl. J. Med. 274, 1460(1966).PubMedGoogle Scholar
  27. Berson, S.A., Yalow, R.S.: Radioimmunassay of ACTH in plasma. J. clin. Invest. 47, 2725(1968).PubMedGoogle Scholar
  28. Bertrand, N.R., Gilbert, J.A.L.: The prednisone glucose tolerance test in the diagnosis of diabetes in woman producing large babies. Canad. med. Ass. J. 83, 753(1960).PubMedGoogle Scholar
  29. Besser, G.M., Landon, J.: Plasma levels of immunoreactive corticotrophin in patients with Cushing’s syndrome. Brit. med. J. 1968 IV, 552.Google Scholar
  30. Betheil, J.J., Feigelson, M., Feigelson, P.: The differential effects of glucocorticoid on tissue and plasma acid levels. Biochim. biophys. Acta (Amst.) 104, 92 (1965).Google Scholar
  31. Bickel, G.: Diabete pancreatique, severe devenu aglycosurique a loccasion du developpement d’une maladie d’Addison. Helv. med. Acta 11, 281(1945).Google Scholar
  32. Bierry, H., Malliozel, L.: Hypoglycaemie apres decapsulation. Effects de l’injection d’adrenaline sur les animaux decapsules. C. R. Soc. Biol. (Paris) 65, 232(1908).Google Scholar
  33. Bock, H.E.: Schaden durch Nebennierensteroide. Internist (Berl.) 3, 459(1962).Google Scholar
  34. Bodo, R.C. de, Altszuler, N.: Insulinhypersensivity and physiological insulin antagonists. Physiol. Rev. 38, 389(1958).Google Scholar
  35. Boland, E.W.: Prednisone and prednisolone therapy in rheumatoid arthritis. J. Amer. med. Ass. 160, 613(1956).Google Scholar
  36. Bondy, P.K.: The effect of the adrenal and thyroid glands upon the rise of plasma aminoacids in the eviscerated rat. Endocrinology 45, 605(1949).PubMedGoogle Scholar
  37. Bottermann, P.: Fruherkennung des Diabetes mellitus. Med. Klin. 64, 49(1969).PubMedGoogle Scholar
  38. Bottermann, P.: Beeinflussung endokriner Parameter durch Ovulationshemmer. Internist (Berl.) 13, 293(1972).Google Scholar
  39. Bottermann, P., Dieterle, P., Hochheuser, W., Horn, K., Kapetz, K., Schleypen, K., Schwarz, K., Scriba, P.C.: Zur Frage der endokrinen Nebenwirkungen von Ovulationshemmern. Einfluß auf Glukosetoleranz, unveresterte Fettsäuren, Insulin und Cortisolspiegel, sowie proteingebundenes Jod und Trijodthyronin im Serum. Münch, med. Wschr. 109, 685(1967).Google Scholar
  40. Bradlow, H.L., Dobriner, K., Gallagher, T.F.: The fate of cortisone-T in mice. Endocrinology 54, 343(1954).PubMedGoogle Scholar
  41. Brooks, R.V., Dupre, J., Cogate, A.N., Mills, J.H., Prunt, F.T.G.: Appraisal of adrenocortical hyperfunction: patients with Cushing’s syndrome or non-endocrine tumors. J. clin. Endocr. 23, 725(1963).PubMedGoogle Scholar
  42. Brown, E. M. jr., Lukens, F.D.W., Elkington, J.R., de Moor, P.: Observations on metabolic and antiarthritic effects of ACTH and cortisone in diabetics. J. clin. Endocr. 10, 163(1950).Google Scholar
  43. Buchler, D., Warren, J. C.: Effects of estrogen on glucose tolerance. Amer. J. Obstet. Gynec. 95, 479(1966).PubMedGoogle Scholar
  44. Bunim, J.J., Kaltmann, A.J., McEwen, C.: Diabetogenic effect of cortisone and ACTH in a nondiabetic patient with rheumatoid arthritis. Amer. J. Med. 12, 125(1952).PubMedGoogle Scholar
  45. Bush, I.E.: The physicochemical state of Cortisol in blood. Ciba Foundation Colloq. Endocri. 11, 263(1957).Google Scholar
  46. Chance, R.E., Ellis, R.M.: Proinsulin. Single-chain precursor of insulin. Arch. intern. Med. 123, 229(1969).PubMedGoogle Scholar
  47. Chimenes, H., Caurier, J., Dekergorlay, B., Russo, F.: Influence des contraceptifs oraux sur le metabolisme glucidique contraception hormonale et diabete sucre. Sem. Hop. Paris 48, 1587(1972).Google Scholar
  48. Clayton, B.E.: Some observations on adrenocorticotrophin in blood. Proc. roy. Soc. Med. 51, 558(1958).PubMedGoogle Scholar
  49. Clinch, J., Turnbull, A. C., Khosia, T.: Effects of O.C. on glucose tolerance. Lancet 1969 I, 857–858.Google Scholar
  50. Collens, W.S., Banowitch, M.M.: Insulin resistance: report of an unusual case with requirements up to 7840 units in 24 hours. Metabolism 4, 355(1955).PubMedGoogle Scholar
  51. Colucci, C.F., Deluca, F.P.: Le indicazioni dei cortisonici nella terapia della cirrosi epatica ascitica. A proposito di 122 casi e 323 osservazioni. Minerva med. 59, 783(1968).PubMedGoogle Scholar
  52. Conn, J.W.: Hypertension the patassium ion and impaired carbohydrate tolerance. New Engl. J. Med. 273, 1135(1965).PubMedGoogle Scholar
  53. Conn, J.W., Fajans, S.S.: Influence of adrenal cortical steroids on carbohydrate metabolism in man. Metabolism 5, 114(1956).PubMedGoogle Scholar
  54. Conn, J.W., Knopf, R.F., Nesbit, R.M.: Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Amer. J. Surg. 107, 159(1964).PubMedGoogle Scholar
  55. Conn, J.W., Louis, L.H., Wheeler, C.E.: Production of temporary diabetes mellitus in man with pitiutary adrenocorticotropic hormone; relation to uric acid metabolism. J. Lab. clin. Med. 33, 651(1948).PubMedGoogle Scholar
  56. Cope, C.L.: Adrenal steroids and disease. London: Pitman Medical Publishing 1965.Google Scholar
  57. Cope, C.L., Raker, J.W.: Cushing disease. The surgical experience in the care of 46 cases. New Engl. J. Med. 253, 119(1955).PubMedGoogle Scholar
  58. Corey, E.L., Britton, S.W.: Hypophyseal and adrenal interrelationships and carbohydrate metabolism. Amer. J. Physiol. 126, 148(1939).Google Scholar
  59. Crampton, J.H., Scudder, S.T., Davis, C.D.: Carbohydrate metabolism in the combination of diabetes mellitus and Addison disease as illustrated by a case. J. clin. Endocr. 9, 245(1949).PubMedGoogle Scholar
  60. Creutzfeldt, W., Beck, K.: Erhebungen über Atiologie, Pathogenese, Therapieerfolge und Uberlebenszeit an einem unausgewahlten Krankengut von 560 Patienten mit Leberzirrhose. Dtsch. med. Wschr. 91, 662(1966).Google Scholar
  61. Creutzfeldt, W., Kuhn, H.A.: Die Therapie der Leber-Zirrhose mit Glukocorticoiden. Dtsch. med. Wschr. 84, 455(1959).PubMedGoogle Scholar
  62. Creutzfeldt, W., Sickinger, K., Frerichs, H.: Diabetes und Lebererkrankungen. In: Handbuch des Diabetes mellitus (Hrsg. Pfeiffer E.F.). München: Lehmanns Verlag 1971.Google Scholar
  63. Criep, L.H.:Triamcinolone in the treatment of allergic conditions. J. Allergy 30, 50(1959).PubMedGoogle Scholar
  64. Cushing, H.: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull. Johns Hopk. Hosp. 50, 137(1932).Google Scholar
  65. Czirczyk, A.: Belastungsteste mit Hormonen und Sulfonylharnstoffen. In: Handbuch des Diabetes mellitus (Hrsg. Pfeiffer E.F.). München: Lehmanns Verlag 1971.Google Scholar
  66. Danowski, T.S., Sabeh, G., Alley, R.A.,: Glucose tolerance prior to and during therapy with contraceptive steroids. Clin. Pharmacol. Ther. 9, 223(1968).PubMedGoogle Scholar
  67. Dardenne, U.: The therapeutic application of anabolic steroids in ophthalmology. Acta endocr. (Kbh.) 39, Suppl. 63, 143(1961).Google Scholar
  68. Daughaday, W.H.: Evidence for two corticoid binding systems in human plasma. J. Lab. clin. Med. 48, 799(1956).Google Scholar
  69. David, D.S., Grieco, M.H., Cushman, P., jr.: Adrenal glucocorticoids after twenty years: A review of their clinically relevant consequences. J. chron. Dis. 22, 637(1970).PubMedGoogle Scholar
  70. Domenici, G., Cozzolino, G., Scianaro, L.: Testosterone propionato ed insulinamia in individui normali. Boll. Soc. ital. Biol. sper. 45, 536(1969).Google Scholar
  71. Dulin, W.E., Barnes, L. E., Glenn, E.M., Lyster, S.C., Collins, E.J.: Biologic activities of some C21 steroids and some 6-methyl steroids. Metabolism 7, 398(1958).PubMedGoogle Scholar
  72. Eisenstein, A.B., Spencer, S., Flatness, S., Brodsky, A.: Carbohydrate synthesis in the isolated perfused rat liver: role of the adrenal cortex. Endocrinology 79, 182(1966).PubMedGoogle Scholar
  73. Engel, F. L.: A consideration of the roles of the adrenal cortex and stress in the regulation of proteinmetabolism. Recent Progr. Hormone Res. 6, 277(1951).Google Scholar
  74. Exton, J.H.: Progress in endocrinology and metabolism gluconeogenesis. Metabolism 21, 945(1972).PubMedGoogle Scholar
  75. Exton, J.H., Friedman, N., Wong, E.H., Brineaux, J.P., Corbin, J.D., Parc, C.R.: Interaction of glucocorticoids with glucagon and epinephrine in the control of gluconeogenesis and glycogenolysis in liver and lipolysis in adipose tissue. J. biol. Chem. 247, 3579(1972).PubMedGoogle Scholar
  76. Exton, J.H., Harper, S.C.: Role of cyclic AMP and glucocorticoids in the activation of hepatic gluconeogeneses by diabetes. Fed. Proc. 31, 243(1972).Google Scholar
  77. Exton, J.H., Jefferson, L. S., BUTCHER, R.W.,: Gluconeogenesis in the perfused liver: The effects of fasting, alloxan diabetes, glucagon, epinephrine, adenosine 3′,5′-monophosphate and insulin. Amer. J. Med. 40, 709(1966).PubMedGoogle Scholar
  78. Exton, J.H., Malette, L. E., Jefferson, L. S., Wong, E.H., Friedman, N., Miller, T.B.J., Parc, C.R.: The hormonal control of hepatic gluconeogenesis. Recent Progr. Hormone Res. 26, 411(1970).PubMedGoogle Scholar
  79. Fain, J.N., Scow, R.O., Chernick, S.S.: Effects of glucocorticoids on metabolism of adipose tissue in vitro. J. biol. Chem. 238, 54(1963).Google Scholar
  80. Fajans, S.S.: Some metabolic actions of corticosteroids. Metabolism 10, 951(1961).Google Scholar
  81. Fajans, S.S.: Cortisone-glucose-tolerance test. J. Amer. med. Ass. 186, 279(1963).Google Scholar
  82. Fajans, S.S., Conn, J.W.: The approach to the prediction of diabetes mellitus by modification of the glucose-tolerance test with cortisone. Diabetes 3, 296(1954).PubMedGoogle Scholar
  83. Fajans, S.S., Conn, J.W.: The early recognition of diabetes mellitus. Ann. N.Y. Acad. Sci. 82, 208(1959).PubMedGoogle Scholar
  84. Fajans, S.S., Schneider, J.M., Schteingart, D.E., Conn, J.W.: The diagnostic value of sodium tolbutamide in hypoglycemic states. J. clin. Endocr. 21, 371(1961).PubMedGoogle Scholar
  85. Felig, P., Pozefsky, T., Marliss, E., Cahill, G.F., jr.: Alanine, key-role in gluconeogenesis. Science 167, 1003(1970).PubMedGoogle Scholar
  86. Fiegel, G., Bargheer, R., Heindorf, M., Fischer, R., Michalik, E.: Der Kortikoid-Glukose-Test zur Verifizierung des latenten Diabetes mellitus. Med. Welt (Stuttg.) 1965, 1408.Google Scholar
  87. Fiegel, G., Kelling, H.W.: Beeinflussung des Stoffwechsels, des Elektrolythaushaltes und des Blutstatus durch Dexamethason. Münch, med. Wschr. 101, 1787(1959).Google Scholar
  88. Fiegel, G., Kukwa, D.: Vergleichende Untersuchungen über die Wirkung verschiedener Glukokorticoide im Kortikoid-Glukose-Toleranz-Test. Int. J. Pharm. 2, 94(1969).Google Scholar
  89. Field, J.B., Marble, A.: Diminished adrenal cortical function in diabetes as shown in eosinophil response to stress of surgery. Proc. Soc. exp. Biol. (N.Y.) 77, 195(1951).Google Scholar
  90. Fraser, R., Albright, F., Smith, P.H.: The value of the glucose tolerance test, the insulin tolerance test and the glucose-tolerance test in the diagnosis of endocrinologic disorders of glucose metabolism. J. clin. Endocr. 1, 297(1941).Google Scholar
  91. Fraser, R., Albright, F., Smith, P.H.: Endocrine disorders and insulin action. Brit. med. Bull. 16, 242(1960).Google Scholar
  92. Frawley, T.F.: The role of the adrenal cortex in glucose and pyruvic acid metabolism in man including the use of intravenous hydrocortisone in acute hypoglycaemie. Ann. N.Y. Acad. Sci. 61, 464(1955).PubMedGoogle Scholar
  93. Frawley, T.F., Kistler, H., Shelley, T.: Effects of antiinflammatory steroids on carbohydrate matabolism with emphasis on hypoglycemic and diabetic states. Ann. N.Y. Acad. Sci. 82, 868(1959).PubMedGoogle Scholar
  94. Frerichs, H., Creutzfeldt, W.: Der experimentelle Diabetes. In: Handbuch der experimentellen Pharmakologie, Bd. XXXII/1: Insulin (Hrsg. Dorzbach, E.). Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  95. Frerichs, H., Willms, B., Creutzfeldt, W.: Further evidence for an inhibition of hepatic gluconeogenesis in hypoglycaemia due to non-insulin producing rumors. Horm. metab. Res. 1, 896(1969).Google Scholar
  96. Friedman, N., Exton, J., Park, C.R.: Interaction of adrenal steroids and glucagon on gluconeogenesis in perfused rat liver. Biochem. biophys. Res. Commun. 29, 113(1967).Google Scholar
  97. Friedman, N., Exton, J., Park, C.R.: Permissive effect of glucocorticoid on the stimulation of gluconeogenesis by glucagon and epinephrine. Role of cyclic adenylate. Fed. Proc. 27, 625(1968).Google Scholar
  98. Froesch, E.R.: Inselzellapparat, Stoffwechsel und Pathophysiologic des Diabetes mellitus. In: Klinik der inneren Sekretion (Hrsg. Labhart, A.). Berlin-Heidelberg-New York: zSpringer 1971.Google Scholar
  99. Fuertes DeLa Haba, A., Vega De Rodriguez, G., Pelegrina, I.: Carbohydrate metabolism in long-term oral contraceptive users. Obstet. and Gynec. 37, 220(1971).Google Scholar
  100. Gaunt, R., Renzi, A.A., Chart, J. J.: Aldosterone — a review. J. clin. Endocr. 15, 621(1955).PubMedGoogle Scholar
  101. Gershberg, M., Javier, Z., Hulse, M.: Glucose tolerance in women receiving an ovulatory suppressant. Diabetes 13, 378(1964).PubMedGoogle Scholar
  102. Gilbert-Dreyfus, G., Chimenes, H., Thervet, F.: Maladie d’Addison et diabete sucre. J. annuelles de Diabetologie 2, 25(1961).Google Scholar
  103. Granner, D.K., Chase, L.R., Aurbach, G.D., Tomkins, G.M.: Tyrosine aminotransferase: Enzyme induction independent of adenosine 3′,5′-monophosphate. Science 162, 1018(1968).PubMedGoogle Scholar
  104. Granner, D.K., Hayashi, S., Thomson, E., Tomkins, G.: Stimulation of tyrosine aminotransferase synthesis by dexamethasone phophate in cell culture. J. molec. Biol. 35, 291(1968).PubMedGoogle Scholar
  105. Gurin, S., Brady, R.O.: The in vitro synthesis of lipids and its hormonal control. Recent Progr. Hormone Res. 8, 571(1953).Google Scholar
  106. Gyorgy, A.: Therapeutische Beeinflussung des Diabetes durch hochwertige Hodenhormone. Wien. med. Wschr. 89, 1024(1939).Google Scholar
  107. Halling, G.R., Michals, E.L., Paulsen, C.A.: Glucose intolerance during ethynodiol diacetatemestranol therapy. Metabolism 16, 465(1967).PubMedGoogle Scholar
  108. Hench, P.S., Ward, L.E.: Rheumatoid arthritis and other theumatic on articular diseases. In: Lukens F.D.W., Medical use of Cortisone including Hydrocortisone and Corticotropin, p. 237. New York: Blakiston Company, Inc. 1954.Google Scholar
  109. Hennemann, D.M., Bunker, J. P.: The pattern of intermediary carbohydrate metabolism in Cushing’s syndrome. Amer. J. Med. 23, 34(1957).Google Scholar
  110. Hennes, A.R., Wajchenberg, B.L., Fajans, S.S., Conn, J.W.: The effect of adrenal steroids on blood levels of pyruvic and alpha-ketoglutaric acid in normal subjects. Metabolism 6, 339(1957).PubMedGoogle Scholar
  111. Henning, H. V., Seifert, J., Seubert, W.: Cortisol induzierter Anstieg der Pyruvatcarboxylaseaktivität in der Rattenleber. Biochim. biophys. Acta (Amst.) 77, 345(1963).Google Scholar
  112. Hills, O.W., Power, M.H., Wilder, R.M.: Diabetes mellitus and Cushing’s syndrome concentration of lactate and pyruvate in blood after ingestion of glucose. Diabetes 1, 351(1952).PubMedGoogle Scholar
  113. Hoet, J. P.: L’exaltation de Taction diabetogene de la cortisone dans la maladie d’Addison. Ann. Endocr. (Paris) 12, 847(1951).Google Scholar
  114. Hornbrook, K.R., Burch, H.B., Lowry, O.H.: Changes in substrate levels in liver during glycogen synthesis induced by lactate and hydrocortisone. Biochem. biophys. Res. Commun. 18, 206(1965).PubMedGoogle Scholar
  115. Houssay, B.A., Rodriguez, R.R., Cardeza, A.F.: Prevention of experimental diabetes with adrenal steroids. Endocrinology 54, 550(1954).PubMedGoogle Scholar
  116. Houtsmuller, A.J.: The therapeutic application of anabolic steroids in ophthalmology. Biochemical results. Acta endocr. (Kbh.) Suppl. 63, 154(1961); Sympos. on anabolic steroids, vol. 3.Google Scholar
  117. Hubener, H.J., Staib, W.H.: Biochemie der Nebennierenrindenhormone. Stuttgart: Thieme 1965.Google Scholar
  118. Illig, H.: Wie behandelt man das Asthmasyndrom mit Kortikoiden? Landarzt 41, 629(1965).PubMedGoogle Scholar
  119. Ingle, D. J.: The production of glycosuria in normal rat by means of 17-hydroxy-l 1-dehydrocorticosterone. Endocrinology 29, 649(1941).Google Scholar
  120. Ingle, D.J.: Experimental steroid diabetes. Diabetes 5, 187(1956).PubMedGoogle Scholar
  121. Ingle, D.J., Sheppard, R., Evans, J. S., Kuizengra, M.H.: A comparison of adrenal steroid diabetes an pancreatic diabetes in rat. Endocrinology 37, 341(1945).PubMedGoogle Scholar
  122. Ingle, D.J., Thorn, G.W.: Comparison of effects of 11-desoxycorticosterone acetate and 17-hydroxy-11-dehydrocorticosterone in partially depancreatized rats. Amer. J. Physiol. 132, 670(1941).Google Scholar
  123. Jackson, W.P.U.: The cortisone-glucose-tolerance test with special reference to the prediction of diabetes (diagnosis of prediabetes). Diabetes 10, 33(1961).PubMedGoogle Scholar
  124. Jahnke, K.: Die Glukose-, Cortison-Glukose-und Rastinonbelastungsproben bei alteren Personen. In: Oberdisse, K., Jahnke, K., Fortschritte der Diabetesforschung, S. 167. Stuttgart: Thieme 1963.Google Scholar
  125. Jahnke, K., Daweke, H., Schilling, W., Ruenauver, R., Oberdisse, K.: Der potentielle Diabetes (sog. Praediabetes). In: Pathogenese des Diabetes mellitus, S. 57. Berlin-Heidelberg-New York: Springer 1967.Google Scholar
  126. Jakobsen, T.: Clinical studies on adrenocortical function in diabetes mellitus. Acta endocr. (Kbh.), Suppl. 41, 5(1958).Google Scholar
  127. Jeanrenaud, B.: Effect of glucocorticoid hormones on fatty acid mobilization and re-esterification in rat adipose tissue. Biochem. J. 103, 627(1967).PubMedGoogle Scholar
  128. Jeanrenaud, B., Renold, A.E.: Studies on rat adipose tissue in vitro VII. Effects of adrenal cortical hormones. J. biol. Chem. 235, 2217(1960).PubMedGoogle Scholar
  129. Jeanrenaud, B., Renold, A.E.: Metabolic effects of corticosteroids. In: Handbuch des Diabetes mellitus (Hrsg. Pfeiffer, E.F.). München: Lehmanns Verlag 1969.Google Scholar
  130. Kaiser, G., Hanusch, A.W.: Zum Wert des Glukose-, Kortison-Glukose-und Tolbutamid-Tests zur Erkennung eines latenten Diabetes mellitus. Med. Welt (Stuttg.) 21, 1331(1968).Google Scholar
  131. Kaiser, H.: Cortisonderivate in Klinik und Praxis. Stuttgart: Thieme 1973.Google Scholar
  132. Kalkhoff, R.K., Richardson, B.L., Stoddard, F. J.: Defective plasma insulin response during prednisolone glucose tolerance tests in subclinical diabetic mothers of heavy infants. Diabetes 17, 37(1968).PubMedGoogle Scholar
  133. Kawai, A., Yates, F.E.: Interference with feedback inhibition of adrenocorticotrophin release by protein binding of corticosterone. Endocrinology 79, 1040(1966).PubMedGoogle Scholar
  134. Kenney, F.T.: Induction of tyrosine-1-a-ketoglutarate transaminase in rat liver. IV. Evidence for an increase in the rate of enzyme synthesis. J. biol. Chem. 237, 3495(1962).PubMedGoogle Scholar
  135. Kenney, F.T.: Hormonal regulation of synthesis of liver enzymes. Mammalian Protein Metabolism 4, 131(1970).Google Scholar
  136. Kinash, B., Haist, R.E.: Effect of ACTH and cortisone on islets of Langerhans and pancreas in intact and hypophysectomized rats. Amer. J. Physiol. 178, 441(1954).PubMedGoogle Scholar
  137. Kinsell, L.W.: Hypophysectomie in unstable diabetics with progressive retinal and renal vascular disease. Bull. N.Y. Acad. Med. 33, 171(1957).PubMedGoogle Scholar
  138. Kinsell, L.W., Lawrence, L., Weyand, R.D.: Hypophysectomy in patients with diabetic vascular disease; clinical and metabolic observations. Amer. J. Med. 19, 295(1955).Google Scholar
  139. Kinsell, L.W., Margan, S., Michaels, G. D.: Evaluation of effect of testosterone propionate upon ketone, carbohydrate and protein metabolism in patient with diabetes mellitus complicated by thyrotoxicosis. J. clin. Invest. 30, 1486(1951).PubMedGoogle Scholar
  140. Kipnis, D.M.: Regulation of glucose uptake by muscle functional significance of permeability and phosphorylating activity. Ann. N.Y. Acad. Sci. 82, 354(1959).Google Scholar
  141. Kitabchi, A.E., Buchanan, K.D., Vance, J. E., William, R.H.: Effect of adrenocorticotropin and glucocorticoids on insulin secretion. J. clin. Endocr. 28, 1479(1968).PubMedGoogle Scholar
  142. Klink, D., Estrich, D.: Plasma-insulin-concentration in Cushing’s syndrome and thyrotoxicosis. Clin. Res. 12, 354(1969).Google Scholar
  143. Knick, B.: Moderne Methoden der Diabetesdiagnostik. Dtsch. Arztebl. 65, 75(1968).Google Scholar
  144. Krebs, H.A., Speake, R., Hems, R.: Acceleration of renal gluconeogenesis by ketone bodies and fatty acids. Biochem. J. 94, 712(1965).PubMedGoogle Scholar
  145. Krüskemper, H.L.: Anabole Steroide (Hrsg. Weitzel, G., Zöllner, N.). Stuttgart: Thieme 1965.Google Scholar
  146. Labhart, A.: Die Nebennierenrinde. In: Klinik der inneren Sekretion (Hrsg. Labhart A.), S. 347. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  147. Labhart, A., Müller, J.: Die Nebennierenrinde, Physiologie. In: Klinik der inneren Sekretion (Hrsg. Labhart A.), S. 298. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  148. Lambert, T.H., Johnson, R.B., Paul, G.R.: Glucose and cortisone-glucose-tolerance in normal and “prediabetic” humans. Ann. intern. Med. 54, 916(1961).PubMedGoogle Scholar
  149. Landau, B.R.: Adrenal steroids and carbohydrate metabolism. Vitam. and Horm. 23, 2(1965).Google Scholar
  150. Landon, J., Wynn, J.V., Cooke, N.C., Kennedy, A.: Effects of anabolic steroid, methandienone, on carbohydrate metabolism in man. Metabolism 11, 501(1962).PubMedGoogle Scholar
  151. Lardy, H.A., Foster, D.O., Shrago, E., Ray, P. D.: Metabolic and hormonal regulation of phosphopyruvate synthesis. Advanc. Enzym. Regulat. 2, 39(1964).Google Scholar
  152. Laron, Z.: Glucosurie effect of anabolic steroids in juvenile diabetes. Helv. paediat. Acta 20, 635(1965).PubMedGoogle Scholar
  153. Lazarow, A.: The relation of gluthathione to the diabetogenic effect of adrenal steroids. Diabetes I, 171(1952).Google Scholar
  154. Leboeuf, B., Renold, A.E., Cahill, G.F.: Studies on rat adipose tissue in vitro. IX. Further effects of Cortisol on glucose metabolism. J. biol. Chem. 237, 988(1962).PubMedGoogle Scholar
  155. Liddle, G.W., Island, D., Meador, C.K.: Normal and abnormal regulation of corticotropin secretion in man. Recent Progr. Hormone Res. 18, 125(1962).Google Scholar
  156. Litwack, G., Sears, M.L., Diamondstone, T.I.: Intracellular distribution of tyrosine-ketoglutarate transaminase and 4-C1 hydrocortisone activities during induction. J. biol. Chem. 238, 302(1963).PubMedGoogle Scholar
  157. Litwack, G., Singer, S.: Subcellular actions of glucocorticoids. In: Biochemical action of hormones, II, p. 113. New York-London: Academic Press 1972.Google Scholar
  158. Long, C.N.H.: Diabetes mellitus in light of our present knowledge of metabolism. Trans. Stud. Coll. Phycns Philad. 7, 121(1939).Google Scholar
  159. Long, C.N.H., Fry, E.G., Bonnycastle, M.: Effect of Cortisol in carbohydrate deposition and urea nitrogen excretion in the adrenalectomized rat. Acta endocr. (Kbh.), Suppl. 51, 819(1960).Google Scholar
  160. Long, C.N.H., Katzin, B., Fry, E.G.: The adrenal cortex and carbohydrate metabolism. Endocrinology 26, 309(1940).Google Scholar
  161. Long, C.N.H., Lukens, F.D.W.: The effects of adrenalectomy and hypophysectomy experimental diabetes in the cat. J. exp. Med. 63, 465(1936).PubMedGoogle Scholar
  162. Lukens, F.D.W., Flippin, H.F., Thigpen, F.M.: Adrenal cortical adenoma with absence of the opposite adrenal report of a case with operation and autopsie. Amer. J. med. Sci. 193, 812(1937).Google Scholar
  163. Maengwyn-Davies, G.D., Lerman, S., Pogell, B.M., Stone, H.H., Friedenwald, J.S.: The adrenal cortex in diabetic retinopathy urinary 17-hydroxycorticosteroid excretion studies. Bull. Johns Hopk. Hosp. 99, 16(1956).Google Scholar
  164. Major, P.W., Kilpatrick, R.: Cyclic AMP and hormone action. J. Endocr. 54, 593(1972).Google Scholar
  165. Maranon, G., Noguera, J. F.: La enfermedad de Addison (estudio de 400 casos). Madrid: Espasa-Calpe 1949.Google Scholar
  166. Marco, J., Calle, C., Roman, D., Diaz-Fierros, M., Villanueva, M., Valverde, J.: Hyperglucagonism induced by glucocorticoid treatment in man. New Engl. J. Med. 288, 128(1973).PubMedGoogle Scholar
  167. Matsui, N., Plager, J.E.: An in vitro physiological activity of protein bound and unbound Cortisol. Endocrinology 78, 1159(1966).PubMedGoogle Scholar
  168. Matsui, N., Plager, J.E.: “Anti-insulin” action of Cortisol 1. Influence of Cortisol on the metabolism of specifically labeled glucose, pyruvate and glucose-6-phosphate. Endocrinology 84, 1439(1969).Google Scholar
  169. McKiddie, M.T., Jasani, M.K., Buchanan, K.D., Boyle, J.A., Buchanan, W.W.: The relationsship between glucose-tolerance plasma insulin and corticosteroid therapie in patients with rheumatoid arthritis. Metabolism 17, 730(1968).PubMedGoogle Scholar
  170. McMahon, F.G.: Steroiddiabetes. J. Louisiana med. Soc. 112, 126(1960).Google Scholar
  171. Meikle, A.W., Klain, G.J., Hannon, J.P.: Inhibition of glucose oxydation and fatty acid synthesis in liver slices from fed, fasted an fasted-refed by glucagon, epinephrine an cyclic adenosine-3-5′-monophosphate. Proc. Soc. exp. Biol. (N.Y.) 143, 379(1973).Google Scholar
  172. Melani, F.: Das immunologisch meßbare Insulin im Blut. Habilitationsschrift, Ulm 1968.Google Scholar
  173. Modigliani, E., Strauch, G., Luton, J.P., Bricaire, H.: Effets du glucose et de l’arginine sur la secretion d’insuline au cours des syndromes de Cushing. Diabetologia 6, 8(1970).PubMedGoogle Scholar
  174. Molnar, G.D., Rosevear, J.W., Gastineau, C.F., Moxness, K.E.: Effects of anabolic steroids on diabetic instability. Amer. J. med. Sci. 249, 280(1965).PubMedGoogle Scholar
  175. Morris, D.J., Barnes, W.F.: On the intracellular distribution of 4-C14 Cortisol in rat liver. Biochim. biophys. Acta (Amst.) 136, 67(1967).Google Scholar
  176. Mortimore, G.E., Irvine, E., Hopper, J., Forsham, P.H.: The functional state of the adrenal cortex in diabetes mellitus. J. clin. Endocr. 16, 932(1956).Google Scholar
  177. Munck, A.: The effect of Cortisol on glucose uptake by rat epididymal fat pads. Endocrinology 68, 178(1961).PubMedGoogle Scholar
  178. Munck, A.: Glucocorticoid inhibition of glucose uptake by peripheral tissues: Old and new evidence molecular mechanism and physiological significance. Perspect. Biol. Med. 14, 265(1971).PubMedGoogle Scholar
  179. Munck, A., Brinck-Johnson, T.: Specific and nonspecific physiochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J. biol. Chem. 243, 5556(1968).PubMedGoogle Scholar
  180. Munck, A., Koritz, S.B.: Studies on the mode of action of glucocorticoids in rats. 1. Early effects of Cortisol on blood glucose and on glucose entry into muscle, liver and adipose tissue. Biochim. biophys. Acta (Amst.) 57, 310(1962).Google Scholar
  181. Nahmer, D.V.D., Miss, H.D., Jahnke, K.: Die Funktion der Nebennierenrinde im diabetischen Koma. Untersuchungen der 11-OHCS im Plasma. Klin. Wschr. 49, 578(1971).PubMedGoogle Scholar
  182. Nahmer, D.V.D., Siedek, M.: Hypothalamus-Hypophysenvorderlappen-Nebennierenrindensystem und Glukosestoffwechsel. Med. Welt 23, 1413(1972).PubMedGoogle Scholar
  183. Nelson, D.H., Sprunt, J.G., Mims, R. B.: Plasma ACTH determination in 58 patients before or after adrenalectomy for Cushing’s syndrome. J. clin. Endocr. 26, 722(1966).PubMedGoogle Scholar
  184. Noall, M.W., Riggs, T. R., Walker, L.M., Christensen, H.N.: Endocrine control of amino acid transfer. Science 126, 1002(1957).PubMedGoogle Scholar
  185. Oakley, G.W., Field, J.B., Sowton, J.V., Rigby, B., Cunliffe, A. C.: Action of prednisone in insulin-resistant diabetes. Brit. med. J. 1959 I, 1601.Google Scholar
  186. Oakley, G.W., Peel, J.: Pregnancy. In: Oakley, G.W., Pyke, D.A., Taylor, K.W. (eds.), Clinical diabetes and its biochemical basis. Oxford-Edinburgh: Blackwell Scientific Publications 1968.Google Scholar
  187. Oberdisse, K.: Die Therapie mit Glucocorticoiden (Substitution, Hemmwirkung, Therapie mit pharmakologischen Dosen). Naunyn-Schmiedeberg’s. Arch. Pharmak. exp. Path. 241, 102(1961).Google Scholar
  188. Oberdisse, K., Blank, H., Hüter, K.: Die Erfassung pradiabetischer Zustande. Klin. Wschr. 40, 446(1962).PubMedGoogle Scholar
  189. Oshawa, N., Kuzuya, T., Tanioka, T., Kanazawa, Y., Ibayashi, H., Nakoa, K.: Effect of administration of ACTH on insulinsecretion in dogs. J. clin. Endocr. 81, 925(1967).Google Scholar
  190. Paola, G., di, Robin, M., Nicholson, R.: Estrogen therapie and glucose tolerance test. Amer. J. Obstet. Gynec. 107, 124(1970).PubMedGoogle Scholar
  191. Papst, K., Theile, U., Orestano, F.: Nebenwirkungen der Steroidbehandlung bei Patienten mit Hepatitis. Therapiewoche 17, 1917(1967).Google Scholar
  192. Park, C. R., Morgan, H.E.: Glucose transport and phosphorylation in muscle of diabetic animals. Diabetes 9, 250(1960).PubMedGoogle Scholar
  193. Perera, G.A., Pines, K.L., Hamilton, H.B., Vislocky, K.: Clinical and metabolic study of 11-dehydro-17-hydroxycorticosterone acetate (Kendall compound E) in hypertension, Addison’s disease and diabetes mellitus. Amer. J. Med. 7, 56(1949).PubMedGoogle Scholar
  194. Perley, M., Kipnis, D.M.: Effect of glucocorticoids on plasma insulin. New Engl. J. Med. 274, 1237(1966).PubMedGoogle Scholar
  195. Persky, M., Linsk, Isaacs, M., Jenkins, J. P., Rosenbluth, M., Kupperman, H.S.: Acute effects of intravenous hydrocortisone on glucose and insulin tolerances and levels of serum and urinary inorganic phosphorus. J. clin. Endocr. 15, 1247(1955).PubMedGoogle Scholar
  196. Peterson, W.F., Steel, M.W., jr., Coyne, R. V.: Analysis of the effect of ovulatory suppressants on glucose tolerance. Amer. J. Obstet. Gynec. 95, 484(1966).PubMedGoogle Scholar
  197. Petrides, P., Weiss, L., Löffler, G., Wieland, O.: Die Zuckerkrankheit. In: Cobet, R., Gutzeit, K., Bock, H.E., Hartmann, F. (Hrsg.), Klinik der Gegenwart, Bd. XI. München-Berlin-Wien: Urban & Schwarzenberg 1970.Google Scholar
  198. Pfeiffer, E.F.: Endokrines System. In: Heintz, R. (Hrsg.): Erkrankungen durch Arzneimittel. Stuttgart: Thieme 1966.Google Scholar
  199. Pfeiffer, E.F.: Obesity and diabetes in man. Diab. Croat. 1, 271(1972).Google Scholar
  200. Pi-Sunyer, F.X., Oster, S.: Effect of an ovulatory suppressant on glucose tolerance and insulin secretion. Obstet. and Gynec. 31, 482(1968).Google Scholar
  201. Plotz, C.M., Knowlton, A.J., Ragan, C.: The natural history of Cushing’s syndrome. Amer. J. Med. 13, 597(1952).PubMedGoogle Scholar
  202. Posner, N.A., Silverstone, F.A., Pomerance, W., Baumgold, D.: Oral contraceptives and intravenous glucose tolerance. 1. Data noted early in treatment. Obstet. and Gynec. 29, 79(1967).Google Scholar
  203. Pote, W.W.H., Poucher, R. L.: Comparative results of three tests for diabetes in normal persons. Diabetes 11 (Suppl.), 132(1962).PubMedGoogle Scholar
  204. Pozefsky, T., Colker, J.L., Langs, H.M.: The cortisone-glucose-tolerance test the influence of age of performance. Ann. intern. Med. 63, 988(1965).PubMedGoogle Scholar
  205. Randle, P.J., Garland, P.B., Hales, C.N., Newsholme, A.E.: The glucose fatty acid cycle. Lancet 1963 I, 785.Google Scholar
  206. Reisert, P.M.: 16-Methylenprednisolon (Decortilen) in klinischer Sicht. Münch, med. Wschr. 104, 1003(1962).Google Scholar
  207. Renold, A.E., Ashmore, J.: Metabolic effects of adrenal corticosteroids. In: Diabetes (ed. R. H. Williams), p. 129. New York: Ed. Hoeber 1960.Google Scholar
  208. Retiene, K., Bayer, J. M.: Langjahrige Verlaufsbeobachtungen des endogenen ACTH-Gehaltes im Blut von 37 Cushingkranken vor und nach totaler Adrenalektomie. Verh. dtsch. Ges. inn. Med. 77, 1051 (1971).Google Scholar
  209. Retiene, K.A., Espinoza, G., Abdel Rahman, G., Marx, K.H., Pfeiffer, E.F.: Untersuchungen über den Transport und die Tagesrhythmik von endogenem ACTH im Blut bei stoffwechselgesunden und Cushing-Kranken. 10. Symp. Dtsch. Ges. f. Endokrinologie 1964, S. 231.Google Scholar
  210. Retiene, K., Espinoza, A., Marx, K.H., Pfeiffer, E.F.: Über das Verhalten von ACTH und Cortisol im Blut von normalen und Kranken mit primarer und Sekundärer Storung der Nebennierenrindenfunktion. I. Nachweis der vermehrten ACTH-Sekretion beim Morbus Cushing. Klin. Wschr. 43, 205(1965).PubMedGoogle Scholar
  211. Riddick, F.A., jr., Reisler, D.M., Kipnis, D.M.: The sugar transport system in striated muscle, effect of growth hormone, hydrocortisone and alloxan diabetes. Diabetes 11, 171(1962).PubMedGoogle Scholar
  212. Rifkin, H., Solomon, S., Lieberman, S.: Role of the adrenal cortex in diabetic retinopathy and nephropathy. Diabetes 7, 9(1958).PubMedGoogle Scholar
  213. Robison, G.A., Bütcher, R.W., Sutherland, E.W.: Cyclic AMP, p. 392. New York and London: Academic Press 1971.Google Scholar
  214. Rosen, F., Nichol, C.A.: Corticosteroids and enzyme activity. Vitam. and Horm. 21, 135(1963).Google Scholar
  215. Rosen, F., Roberts, N.R., Budnick, L.E., Nichol, C.A.: An enzymatic basis for the gluconeogenic action of hydrocortisone. Science 127, 287(1958).PubMedGoogle Scholar
  216. Ross, B.D., Hems, R., Krebs, H.A.: The rate of gluconeogenesis from various precursors in the perfused rat liver. Biochem. J. 102, 942(1967).PubMedGoogle Scholar
  217. Rubenstein, A.M., Sooja, C., Steiner, D.F.: Evidence for proinsulin in human urine and serum. Lancet 1968 I, 1353.Google Scholar
  218. Rull, J.A., Conn, J.W., Floyd, J. C., Fajans, S.S.: Levels of plasma insulin during cortisone glucose tolerance test in “nondiabetic” relatives of diabetic patients. Diabetes 19, 1(1970).PubMedGoogle Scholar
  219. Russi, S., Blumenthal, H.T., Gray, S.H.: Small adenomas of adrenal cortex in hypertension and diabetes. Arch. intern. Med. 76, 284(1945).Google Scholar
  220. Ryan, W.G., Schwartz, T.B., Nibbe, A.F.: Serum immunoreactive insulin levels during glucose tolerance and intensive islet stimulation. Diabetes 20, 404(1971).PubMedGoogle Scholar
  221. Sachse, B., Yazdanfar, A.: Diagnostische Kriterien des Fnihdiabetes. Dtsch. med. Wschr. 93, 57(1968).Google Scholar
  222. Sanders, M.J.: Effect of prednisolone on glucose tolerance in respect to age and family history of diabetes mellitus. Diabetes 10, 41(1957).Google Scholar
  223. Sauer, H., Rausch-Stroomann, J.G.: Klinik und Therapie des Steroiddiabetes. Dtsch. med. Wschr. 89,2130(1964).PubMedGoogle Scholar
  224. Sayer, G.: The adrenal cortex and homeostasis. Physiol. Rev. 30, 241(1950).Google Scholar
  225. Schaeffer, L.D., Chenoweth, M., Dunn, A.: Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity. Biochim. biophys. Acta (Amst.) 192, 292(1969).Google Scholar
  226. Schaeffer, L.D., Chenoweth, M., Dunn, A.: Adrenal corticosteroid involvement in the control of phosphorylase in muscle. Biochim. biophys. Acta (Amst.) 192, 304(1969).Google Scholar
  227. Schmidt, M.B.: Eine biglandulare Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addison. Verh. dtsch. Ges. Path. 12, 212(1926).Google Scholar
  228. Schoner, W., Haag, U., Seubert, W.: Regulation of carbohydrate metabolism by Cortisol independent of the de novo synthesis of enzymes in rat liver. Hoppe Seylers Z. physiol. Chem. 351, 1071(1970).PubMedGoogle Scholar
  229. Schreiner, W.E.: Ovar. In: Klinik der inneren Sekretion (Hrsg. Labhart, A.), S. 523. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  230. Schriefers, H.: Factors regulating the metabolism of steroids. Vitam. and Horm. 25, 271(1967).Google Scholar
  231. Schteingart, D.E., Gregerman, R.J., Conn, J.W.: A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing’s syndrome. Metabolism 12, 484(1963).PubMedGoogle Scholar
  232. Schubert, G.E., Schulte, H.D.: Beitrag zur Klinik des Steroiddiabetes. Dtsch. med. Wschr. 88, 1174(1963).Google Scholar
  233. Schwarz, K., Weinges, K.F., Eumer, K.P., Kopetz, K.: Das Verhalten der insulin-ahnlichen Aktivität bei Patienten mit einem Cushing-Syndrom während einer Glukose-Doppelbelastung. Verh. dtsch. Ges. inn. Med. 68, 289(1962).Google Scholar
  234. Seltzer, H.S.: Diagnosis of diabetes. In: Diabetes mellitus (theory and practice) (eds. Ellenberg M., Rifkin H.). New York: McGraw-Hill 1970.Google Scholar
  235. Shrago, E., Lardy, H.A.: Paths of carbon in gluconeogenesis and lipogenesis. II. Conversion of precursors to phosphoenolpyruvate in liver cytosol. J. biol. Chem. 241, 663(1966).PubMedGoogle Scholar
  236. Siede, W., Klamp, A.: Die Behandlung der akuten Virushepatitis mit Corticoid-Derivaten. Dtsch. med. Wschr. 85, 333(1960).PubMedGoogle Scholar
  237. Siegenthaler, W., Schönbeck, M., Werning, C.: Nebenniere. In: Klin. Pathophysiologic, S. 306. Stuttgart: Thieme 1970.Google Scholar
  238. Simpson, J.R.: Steroiddiabetes. Harper Hosp. Bull. 15, 43(1957).PubMedGoogle Scholar
  239. Skillern, P.G., Mccullagh, E.P.: Hyperfunction and hypofunction of endocrine glands and diabetes mellitus. J. Indiana med. Ass. 50, 701(1957).PubMedGoogle Scholar
  240. Slaton, P.E., Biglieri, E.G.: Hypertension and hyperaldosteronism of renal and adrenal origin. Amer. J. Med. 38, 324(1965).PubMedGoogle Scholar
  241. Slaunwhite, W.R., jr., Lockie, G.N., Bach, N., Sandberg, A.A.: Inactivity in vivo of transcortinbound Cortisol. Science 135, 1062(1962).PubMedGoogle Scholar
  242. Slaunwhite, W. R., Sandberg, A.A.: Transcortin A corticosteroid-binding protein of plasma. J. clin. Invest. 38, 384(1959).PubMedGoogle Scholar
  243. Smith, O.K., Long, C.N.H.: Effect of Cortisol on the plasma amino nitrogen of eviszerated-adrenalectomized diabeticats. Endocrinology 80, 561(1967).PubMedGoogle Scholar
  244. Söling, H.D., Kattermann, R., Schmidt, H.: The relationship between the cytoplasmatic redox-state and ketogenesis in the liver cell and the problem of the triosephosphate block in diabetes mellitus. Excerpta medica, Intern. Congr. Ser. 74, 55(1964).Google Scholar
  245. Soffer, L.J., Jannacone, A., Gabrilove, J.: Cushing’s syndrome, a study of fifty patients. Amer. J. Med. 30, 129(1961).Google Scholar
  246. Solomon, N., Carpenter, C.C.J., Bennet, I.L., jr., Harvey, A. MCG.: Schmidt’s syndrome (thyroid and adrenal insufficiency) and coexistent diabetes mellitus. Diabetes 14, 300(1965).Google Scholar
  247. Spellacy, W. N.: A review of carbohydrate metabolism and the oral contraceptives. Amer. J. Obstet. Gynec. 104, 448(1969).PubMedGoogle Scholar
  248. Spellacy, W. N., Carlson, K.L., Birks, S.A., Schade, S.L.: Glucose and insulin alterations after one year of combination-type oral contraceptive treatment. Metabolism 17, 496(1968).PubMedGoogle Scholar
  249. Spellacy, W. N., Carlson, K.L., Schade, R.M.: Menstrual cycle carbohydrate metabolism. Amer. J. Obstet. Gynec. 99, 382(1967).PubMedGoogle Scholar
  250. Sprague, R.G., Gastineau, C.F., Mason, H.L., Power, M.H.: Effects of synthetic 11-dehydrocorticosterone (compound A) in a subject with Addison’s disease. Amer. J. Med. 4, 175(1948).PubMedGoogle Scholar
  251. Sprague, R.G., Hayles, A.B., Power, M.W., Mason, H.L., Bennett, W. A.: “Steroid diabetes” and alkalosis associated with Cushing’s syndrome, report of case isolation of 17-hydroxycorticosterone (compound F) from urine and metabolic studies. J. clin. Endocr. 10, 289(1950).Google Scholar
  252. Sprague, R.G., Mason, H.L., Power, M.H.: Studies of the effects of adrenal cortical hormones on carbohydrate metabolism in human subjects. Proc. Amer. Diab. Ass. 9, 147(1949).Google Scholar
  253. Sprague, R.G., Power, M.H., Mason, H.L., Albert, A., Mathieson, D.R., Hench, P.S., Kendall, E.C., Slocum, C.H., Polley, H.F.: Observations on the physiological effects of cortisone and ACTH in man. Arch. intern. Med. 85, 199(1950).Google Scholar
  254. Sprague, R.G., Randall, R.V., Salassa, R.M., Scholz, D.A., Priestley, J.T., Walters, W., Bulbulian, A.H.: Cushing’s syndrome: A progressive and often fatal disease, a review of 100 cases seen between July 1945 and July 1954. Scientific exhibit. Arch. intern. Med. 98, 389(1956).Google Scholar
  255. Stanton, E.R., Jones, H.W., jr., Marble, A.: Coexisting diabetes mellitus and Addison’s disease: observations and report of a case in a 10-year-old boy. Arch. intern. Med. 93, 911(1954).Google Scholar
  256. Streeten, B.H.P., Gerstein, M.M., Marmor, B.M., Doisy, R. J.: Reduced glucose tolerance in elderly human subjects. Diabetes 14, 579(1965).PubMedGoogle Scholar
  257. Struck, E., Ashmore, J., Wieland, O.: Stimulierung der Glukoneogenese durch langkettige Fettsäuren und Glukagon. Biochem. Z. 343, 107(1965).PubMedGoogle Scholar
  258. Struck, E., Ashmore, J., Wieland, O.: Pyruvatcarboxylase-Aktivität und Glukoseneubildung in der isoliert perfundierten Rattenleber. Enzymol. biol. clin. 7, 38(1966).Google Scholar
  259. Szücs, S., Csapo, G.: Hypophyseo-adrenal function in diabetic angiopathy. Acta endocr. (Kbh.) 46, 135(1964).Google Scholar
  260. Tacàc, A., Bruns, W., Langsch, H.G., Vetter, K., Kublun, G.: Vergleichende Untersuchungen mit Prednison-Kurztherapie bei Diabetikern und Nichtdiabetikern mit chronischer Hepatitis und Leberzirrhose unter besonderer Berücksichtigung des Kohlenhydratstoffwechsels. Dtsch. Z. Verdau.-u. Stoffwechselkr. 25, 312(1965).Google Scholar
  261. Tainter, M.L., Arnold, A., Beyler, A.L., Potts, G.O., Roth, C.H.: Anabolic steroids in the management of the diabetic patient. N.Y. St. J. Med. 64, 1001(1964).Google Scholar
  262. Talbot, N.B., Wood, M.S., Worcester, J., Christo, E., Cambell, A.M., Zygmuntowicz, A.S.: Further observations on the urinary excretion of water-soluble corticosteroids by normal and abnormal subjects. J. clin. Endocr. 11, 1224(1951).PubMedGoogle Scholar
  263. Tamm, J.: Testis. In: Klin. Pathophysiologic (Hrsg. Siegenthaler W.), S. 336. Stuttgart: Thieme 1970.Google Scholar
  264. Taylor, M.B., Kass, M.B.: Effect of oral contraceptives on glucose metabolism. Amer. J. Obstet. Gynec. 102, 1035(1968).PubMedGoogle Scholar
  265. Tepperman, J., Tepperman, H.M.: Gluconeogenesis, lipogenesis and the sherringtonian metaphor. Fed. Proc. 29, 1284(1970).PubMedGoogle Scholar
  266. Thaddea, S., Hampe, H.: Über den Einfluß der Sexualhormone auf die Stoffwechsellage des Altersdiabetes. Z. klin. Med. 137, 760(1940).Google Scholar
  267. Tharandt, L., Diekers, R.I., Breuer, N., Staib, W.: Effects of testosterone on glucagon and lactate-induced gluconeogenesis with the model of isolated perfused (without hemoglobin) micelivers. 20. Symp. Dtsch. Ges. Endokr. Tübingen 1974 (Referat).Google Scholar
  268. Thompson, E.B., Lippman, M.E.: Mechanism of action of glucocorticoids. Metabolism 23, 159(1974).PubMedGoogle Scholar
  269. Thorn, G.W., Forsham, P.H., Bennett, L.L., Roche, M., Reiss, R.S., Slessor, A., Flink, E.B., Somerville, W.: Clinical and metabolic changes in Addison’s disease following the administration of compound E acetat. Trans. Ass. Amer. Phycns 62, 233(1949).Google Scholar
  270. Thorn, G.W., Koepf, G.F., Lewis, R.A., Olsen, E.F.: Carbohydrate metabolism in Addison’s disease. J. clin. Invest. 19, 813(1940).PubMedGoogle Scholar
  271. Thorn, G.W., Renold, A.E., Cahill, G. F.: The adrenal and diabetes-some interactions and interrelations. Diabetes 8, 337(1959).PubMedGoogle Scholar
  272. Thorn, G.E., Renold, A.E., Winegrad, A.I.: Some effects of adrenal cortical steroids on intermediary metabolism. Brit. med. J. 1957 II, 1009.Google Scholar
  273. Turkington, R.W., Lebowitz, H.E.: Extraadrenal endocrine deficienies in addison’s disease. Amer. J. Med. 43, 499(1967).PubMedGoogle Scholar
  274. Tzargournis, M., Hamwi, G. J.: The prevalence of diabetes mellitus in patients with addison’s disease: Measurements of serum insulin levels. Metabolism 16, 213(1967).Google Scholar
  275. Utter, M.F., Scrutton, M.C.: Pyruvate carboxylase. Curr. Top. cell. Regulat. 1, 253(1969).Google Scholar
  276. Vermeulen, A., Daneels, R., Thiery, M.: Effects of oral contraceptives on carbohydrate metabolism. Diabetologia 6, 519(1970).PubMedGoogle Scholar
  277. Wajchenberg, B.L., Pupo, A.A., Machado, M.M., Mattar, E., Schnaider, J., Pereira, V.G., Gelman, A., Ulhua Cintra, A.B.: Glucose tolerance and cortisoneglucose tolerance in children relatives of known diabetic patients 4. Congres de la F.I.D., ed. Medicine et Hygiene, vol. 11, p. 229, Geneve 1961.Google Scholar
  278. Weber, G., Singhal, R.L.: Role of enzymes in homeostasis V. Actinomycin and puromycin inhibition of cortisone-induced synthesis of hepatic glucose-6-phosphatase and fructose 1,6-diphosphatase. J. biol. Chem. 239, 521(1964).PubMedGoogle Scholar
  279. Webster, B.H., Hurt, J. E.: The concomitance of diabetes mellitus and Addison’s disease. Diabetes 6, 436(1957).PubMedGoogle Scholar
  280. Weisenfeld, S.: Effect of 17-ethyl-19-nortestosterone on hyperglycemic action of glucagon in humans. Proc. Soc. exp. Biol. (N.Y.) 97, 764(1958).Google Scholar
  281. Welt, I.D., Destetten, W., jr., Ingle, D.J., Morley, E.H.: Effect of cortisone upon rates of glucose production and oxydation in rat. J. biol. Chem. 197, 57(1952).PubMedGoogle Scholar
  282. West, K. M.: Comparison of the hyperglycemic effects of glucocorticoids in human beings. The effect of heredity on responses to glucocorticoids. Diabetes 6, 168(1957).PubMedGoogle Scholar
  283. West, K. M.: Relative eosinopenic and hyperglycemic potencies of glucocorticoids in man. Metabolism 7, 441(1958).PubMedGoogle Scholar
  284. Westphal, U.: Binding of hormons to serumproteins. In: Biochemical actions and hormons (ed. Litwack G., vol. 1, p. 259. New York-London 1970.Google Scholar
  285. Wilbert, L., Hillmer, T., Hunstein, W., Reisert, P., Kaboth, U., Creutzfeldt, W.: Einfluß oraler Ovulationshemmer auf klinisch-chemische Normalwerte. Dtsch. med. Wschr. 94, 844(1969).PubMedGoogle Scholar
  286. Wilson, D.L., Frawley, T.F., Forsham, P.H., Thorn, G.W.: The functional relationship between the pancreatic islets and the adrenal cortex in man. Proc. Amer. Diabetes Ass. 10, 25(1950).Google Scholar
  287. Willms, B.: Zur Regulation der Glukoneogenese in der Leber. Habilitationsschrift Göttingen 1970.Google Scholar
  288. Winkelmann, W., Bethge, H., Hackenberg, K., Heesen, D., Mies, R., Zimmermann, H.: Untersuchungen zur Cortisol und Cortisol und Corticosteronsekretion bei unterschiedlichen Formen des Cushing-Syndroms. Verh. dtsch. Ges. inn. Med. 77, 1051(1971).PubMedGoogle Scholar
  289. Wise, J. K., Hendler, R., Felig, P.: Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J. clin. Invest. 52, 2774(1973).PubMedGoogle Scholar
  290. Wolff, H.P., Barth, CH., Distler, A., Dusterdiek, G., Kruck, F., Roscher, S., Vescei, P., Weinges, K. F.: Hypokaliaemischer und normokaliaemischer primarer Aldosteronismus. Dtsch. med. Wschr. 94, 760(1969).PubMedGoogle Scholar
  291. Wool, I.G., Weinshelbaum, E.I.: Incorporation of C14-amino acids into protein of isolated diaphragms: Role of the adrenal gland steroids. Amer. J. Physiol. 197, 1089(1959).PubMedGoogle Scholar
  292. Wynn, V., Doar, J.W.H.: Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966 II, 715.Google Scholar
  293. Yen, S.C.C., Vela, P.: Effects of contraceptive on carbohydrate metabolism. J. clin. Endocr. 28, 1564(1968).PubMedGoogle Scholar
  294. Zicha, L., Feig, A.W.: Vergleichende Untersuchungen über den Einfluß von Paramethason und Betamethason auf die orale und intravenöse Glukosetoleranz. Arzneimittel-Forsch. 17, 1582(1967).Google Scholar
  295. Zicha, L., Kittenberg, H.: Glucocorticoide und Glucosestoffwechsel. III. Mitteilung. Arzneimittel-Forsch. 16, 797(1966).Google Scholar
  296. Zicha, L., Kramer, R., Scheifferth, F., Bergner, D.: Glucocorticoide und Glucosestoffwechsel. I. Mitteilung. Arzneimittel-Forsch.16785 (1966).Google Scholar
  297. Zimmermann, H.: Klinik und Differentialdiagnose des Cushing-Syndroms. 11. Symp. d. dtsch. Ges. f. Endokrinologie Düsseldorf. Berlin-Göttingen-Heidelberg-New York: Springer 1964.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1975

Authors and Affiliations

  • H. Zimmermann

There are no affiliations available

Personalised recommendations